Lenalidomide and Decitabine in High Grade Myelodysplastic Syndromes
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out what dose of lenalidomide is safe to use in
combination with decitabine when given in people with myelodysplastic syndrome.